GRP logo
Clinical Outcomes Assessment – Emerging Good Practices

Clinician-Reported Outcome Assessments of Treatment Benefit: Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task Force

The citation for this report is:
Powers III, JH, Patrick DL, Walton MK, et al. Clinician-Reported Outcome (ClinRO) Assessments of Treatment Benefit: Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task Force. Value Health 2017; 20(1):2-14.

Reflections on ISPOR’s Clinician-Reported Outcomes Good Measurement Practice Recommendations

Joseph C. Cappelleri, PhD, Linda S. Deal, MS, Charles D. Petrie, PhD

Clinical Outcome Assessments: Conceptual Foundation—Report of the ISPOR Clinical Outcomes Assessment – Emerging Good Practices for Outcomes Research Task Force

The citation for this report is:
Walton MK, Powers JA, Hobart J, et al.  Clinical outcome assessments: A conceptual foundation – Report of the ISPOR Clinical Outcomes Assessment Emerging Good Practices Task Force. Value Health 2015; 18:741-52.

Editorial: ISPOR Task Force for Clinical Outcomes Assessment: Clinical Outcome Assessments: Conceptual Foundation—Report of The ISPOR Clinical Outcomes Assessment – Emerging Good Practices for Outcomes Research Task Force

Karin S. Coyne, PhD, MPH & Kathleen W. Wyrwich, PhD, Evidera, Bethesda, MD, USA

Webinars Icon » Webinar

Co-Chairs:
John H. Powers, III, MD, FACP FIDSA, Professor, Clinical Medicine, George Washington University School of Medicine, Washington, DC, USA
Marc K. Walton, MD, PhD, Senior Scientific Director, Janssen Research & Development, Ashton, MD, USA and Former Associate Director for Translational Medicine
Office of Translational Sciences, CDER, Food & Drug Administration (FDA), Silver Spring, MD, USA

Leadership Group:
Laurie B. Burke, RPh, MPH, Founder, Lora Group, LLC and Associate Professor, University of Maryland School of Pharmacy, Baltimore, MD, USA
Stefan Cano, PhD, CPsychol, AFBPsS, Chief Science Officer, Modus Outcomes, Letchworth Garden City, England, UK
Jeremy Hobart, PhD, FRCPJ, Professor, Clinical Neurology and Health Measurement, Peninsula College of Medicine and Dentistry, Plymouth, UK
Maria Isaac, MASc, MD, PhD, MFPM, Senior Scientific Officer, Institute of Medicine of the National Academy of Science, European Medicines Agency, London, England, UK
Patrick Marquis, MD, MBA, President, Modus Outcomes, Newtown, MA, USA
Elizabeth Molsen, RN, Director, Scientific & Health Policy Initiatives, ISPOR, Lawrenceville, NJ, USA
Donald Patrick, PhD, MSPH, Professor, Department of Health Services and Director, Seattle Quality of Life Group, University of Washington, Seattle, WA, USA
Ashley Slagle MS, PhD, Principal, Aspen Consulting Services, LLC, Philadelphia, PA, USA
Spiros Vamvakas MD, Head of Scientific Advice and Professor, Pharmacology, European Medicines Agency, London, England, UK

Activities:

Developing and Evaluating Clinician-Reported Outcomes (ClinROs) – A Case Study on Application of Emerging Good Practices
May 2016 – 21st Annual International Meeting, Forum Presentation, Washington, DC, USA


ISPOR Good Practices For Outcomes Research Index